Page 57 - Human Use News Today

Each year in Europe more than 550,000 patients are diagnosed with breast cancer, of whom 70% have estrogen receptor (ER)-positive disease?; more than 147,000 breast cancer patients in Europe die annually from the disease?If approved by the European

ViiV Healthcare received a positive opinion from the European Medicines Agen

Addendum to M7(R2)

M7(R2) Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals To Limit Potential Carcinogenic Risk—Questions and Answers

The European Medicines Agency’s Committee for Medicinal Products for Human Use issued a negative opinion on the conditional marketing authorization application for adagrasib for the treatment of patients with KRAS G12C–mutated advanced non–small cell lung cancer.

In June, ritlecitinib was approved in the United States and Japan for the treatment of severe alopecia areata in adults and adolescents 12 years and older.

Oregon becomes the 12th state with a comprehensive consumer data privacy law - The Oregon Consumer Privacy Act (OCPA) became law on July 18, 2023. Oregon is the twelfth...

PARIS, July 21, 2023 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today the publication of the results of its European,...

Talquetamab is the first therapy targeting GPRC5D to receive a positive CHMP Opinion Teclistamab, the first BCMA-targeting bispecific antibody to...

By Chris Wack Jazz Pharmaceuticals said Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive...